ZTS Chart

1 Month

	Date	Diff
	2025-04-24	+0.92 %
Zoetis Inc. (NYSE: ZTS) saw a 0.92% increase in its stock price, despite analysts lowering Q1 2025 earnings estimates, likely due to positive earnings results that exceeded consensus estimates for a previous quarter and sustained institutional interest in the company's shares.
	2025-04-23	+0.61 %
The article discusses Zoetis (ZTS) stock's recent performance, highlighting that it was up by 0.61% and touches upon investment topics surrounding Bill Gates' portfolio, including major holdings like Danaher Corporation (DHR). Zoetis's stock may have risen due to overall market trends, strong fundamentals in the healthcare sector, and investor interest in its products, which are considered essential and have pricing power.
	2025-04-16	-1.65 %
Zoetis (ZTS) stock fell by 1.65% after Stifel Nicolaus downgraded its target price from $180.00 to $165.00, indicating reduced expectations for the company's future performance.
	2025-04-09	+6.33 %
Zoetis Inc. (ZTS) experienced a 6.33% increase in stock price due to a significant rise in call options trading, indicating strong investor interest, possibly driven by positive earnings performance and favorable analyst ratings.
	2025-04-02	+0.98 %
Shares of Zoetis Inc. (NYSE:ZTS) rose by 0.98% due to a generally positive sentiment among analysts, who have assigned an average rating of "Buy" to the stock, along with favorable earnings results and a recent dividend announcement.
	2025-03-17	+2.42 %
Zoetis (ZTS) stock rose by 2.42% last night, likely influenced by strong institutional ownership and positive analyst sentiment, as indicated by recent comparisons with other companies in the medical sector.
	2025-03-11	-4.31 %
Zoetis Inc. (ZTS) saw its stock decline by 4.31% following Zacks Research's revision of its FY2026 earnings per share estimates downward from $6.97 to $6.55, raising concerns among investors about the company's financial outlook.
	2025-03-10	+0.84 %
Zoetis (ZTS) stock rose by 0.84% after being upgraded from a hold to a buy rating by StockNews.com, contributing to an overall positive sentiment reflected by increased price targets from various analysts.
	2025-02-27	-0.01 %
Zoetis (ZTS) stock experienced a slight decline of 0.01% following a downgrade from a "buy" to a "hold" rating by StockNews.com, along with reduced price targets from several analysts.
	2025-02-18	-0.66 %
Zoetis Inc. (ZTS) shares fell by 0.66% after analysts at William Blair reduced their Q1 2025 EPS estimates, highlighting concerns about its earnings outlook despite the company recently reporting quarterly earnings that exceeded expectations.
	2025-02-13	-5.15 %
Zoetis (ZTS) stock fell 5.15% after the company provided 2025 guidance that disappointed investors, indicating slower growth despite beating earnings estimates in its fourth quarter. Zoetis (ZTS) stock experienced a decline of 5.15%, attributed to factors affecting investor sentiment and market performance not detailed in the article. Zoetis (ZTS) stock dropped 5.15% after the company reported fourth-quarter earnings of $1.40 per share, exceeding analyst expectations of $1.36, but likely disappointing investors with a sales figure of $2.32 billion that may not have met market expectations.
	2025-02-12	-0.24 %
Zoetis Inc. (ZTS) stock fell by 0.24% following a downgrade in Q1 2025 earnings estimates by analysts at Leerink Partners, who reduced the expected earnings per share from $1.49 to $1.43, contributing to decreased investor confidence. Zoetis (ZTS) stock fell by 0.24% following a downgrade in its price target from Piper Sandler, which lowered it from $210 to $200, contributing to less investor confidence despite maintaining an “overweight” rating.
	2025-02-06	-0.88 %
Zoetis (ZTS) stock has experienced a decline of 0.88% as investors await the upcoming earnings report, which may have contributed to the cautious sentiment surrounding the stock.
	2025-02-04	+0.17 %
Zoetis Inc. (ZTS) experienced a 0.17% increase in stock value, driven by significant purchasing activity from institutional investors, including Chicago Partners Investment Group, which raised its stake in the company, as well as positive earnings results that exceeded analyst expectations and announcements of a dividend increase.
	2025-02-03	+0.61 %
Zoetis Inc. (NYSE: ZTS) stock rose 0.61% following the release of a quarterly earnings report that exceeded analyst expectations and the announcement of an increased dividend, despite a revision downward of Q1 2025 earnings estimates by William Blair.
	2025-01-28	-1.51 %
Zoetis Inc. (NYSE: ZTS) experienced a 1.51% drop in stock price, attributed to a combination of recent stock performance fluctuations, various analysts adjusting their price targets, and broader market factors impacting investor sentiment.
	2025-01-27	+2.62 %
Zoetis Inc. (NYSE:ZTS) stock rose by 2.62% following a strong increase in institutional investment, including a notable 31.4% position boost by Mutual Advisors LLC, and positive earnings performance that exceeded analyst expectations. Zoetis (ZTS) stock rose by 2.62% following a series of positive adjustments by various institutional investors and favorable analyst ratings, indicative of strong confidence in the company's performance and its promising earnings report exceeding expectations. The article discusses a viral TikTok video of a cat named Haru learning to open a door, which highlights the intelligence of cats and aligns with Zoetis Petcare's emphasis on positive reinforcement training methods for pets, coinciding with a 2.62% increase in Zoetis (ZTS) stock likely due to rising interest in pet care products and services.
	2025-01-21	+0.99 %
Zoetis Inc. (ZTS) stock rose 0.99% following an increase in institutional ownership, with several hedge funds boosting their positions, strong quarterly earnings that exceeded expectations, and a raised dividend, signaling investor confidence and positive market sentiment.
	2025-01-17	-2.05 %
Zoetis Inc. (NYSE:ZTS) stock fell by 2.05% despite analysts generally recommending a "buy" rating, as concerns may have arisen from a recent downgrade in target price from Stifel Nicolaus and potential market volatility. Zoetis Inc. (ZTS) stock dropped 2.05% as recent activity indicated a significant adjustment by institutional investors, with several funds increasing their stakes, potentially leading to market volatility despite the company reporting strong earnings. The decline could be attributed to profit-taking or market adjustments following heightened investor interest. Zoetis Inc. (NYSE:ZTS) stock fell by 2.05% as AdvisorNet Financial Inc reduced its stake by 5.6%, amid mixed institutional investor activity, and potential market adjustments following recent earnings reports and changes in analyst ratings.
	2025-01-16	+1.32 %
Zoetis (ZTS) stock rose by 1.32% following a solid earnings report that exceeded analyst expectations, alongside positive news regarding a dividend increase and favorable ratings from multiple analysts.
	2025-01-08	+0.94 %
Zoetis (ZTS) stock increased by 0.94% as analysts continue to express positive sentiment, with multiple upgrades and a consensus rating of "Buy" despite a recent price target reduction by Stifel Nicolaus. The stock's rise can be attributed to strong earnings performance, including an EPS beat and impressive revenue growth, as well as the announcement of an increased quarterly dividend.
	2025-01-07	-1.45 %
Zoetis Inc. (NYSE: ZTS) stock experienced a decline of 1.45%, attributed to various institutional investors adjusting their holdings and market reactions to recent earnings reports and analysts' ratings, despite the company showing strong revenue growth and positive earnings.
	2025-01-06	+1.59 %
Zoetis Inc. (ZTS) stock rose 1.59% following significant increases in holdings by institutional investors, including a 55.6% boost from Pensionfund Sabic, which suggests increased confidence in the company's performance and potential for future growth. Zoetis Inc. (ZTS) stock rose by 1.59% due to a mix of institutional investment activity, strong quarterly earnings that exceeded expectations, and positive analyst ratings and target price adjustments. Zoetis Inc. (ZTS) stock rose by 1.59% as several institutional investors significantly increased their holdings, along with positive analyst ratings and strong earnings performance, indicating investor confidence in the company's growth prospects. Zoetis Inc. (NYSE: ZTS) saw a 1.59% increase in its stock price, attributed to favorable earnings results that exceeded analyst expectations, changes in analyst ratings towards more positive outlooks, and increased institutional investments in the company.
	2024-12-20	+0.81 %
Shares of Zoetis Inc. (NYSE:ZTS) rose by 0.81% after receiving an average "Buy" rating from eleven analyst firms, with several analysts upgrading their target prices and ratings for the stock due to positive quarterly earnings results that exceeded expectations.
	2024-12-10	-0.81 %
Zoetis (ZTS) stock fell by 0.81% due to broader market volatility and concerns among CFOs regarding trade and monetary policy, despite the company's consistent growth in the animal health sector driven by strong demand for pet and livestock products.
	2024-12-06	+0.97 %
Zoetis Inc. (ZTS) experienced a 0.97% increase in its stock price following positive FY2024 earnings per share estimates from Leerink Partners, which forecasted earnings to surpass consensus expectations, alongside several upgraded price targets and ratings from multiple analysts indicating strong market confidence in the company. Zoetis (NYSE:ZTS) stock rose by 0.97% despite analysts reducing their Q2 2025 earnings estimates due to strong quarterly earnings results that surpassed estimates, alongside several upgrades in target prices and positive ratings from multiple equity analysts.
	2024-12-05	-0.31 %
Zoetis (ZTS) stock experienced a 0.31% decline despite a recent upgrade to a strong-buy rating by Leerink Partners, along with positive earnings forecasts and multiple analysts raising their price targets, likely due to broader market movements or investor sentiment.
	2024-12-04	-0.92 %
Zoetis (ZTS) stock experienced a decline of 0.92%, despite recent positive analyst ratings and price target increases from firms like Leerink Partners and Piper Sandler, suggesting a potential upside in the stock's value. The decline may be attributed to overall market trends, investor sentiment, or profit-taking following the stock's recent performance, rather than negative company-specific news.
	2024-11-29	-0.84 %
Zoetis Inc. (NYSE:ZTS) stock declined by 0.84% after Zacks Research reduced its Q2 2025 earnings estimates for the company, forecasting earnings of $1.66 per share instead of the previously estimated $1.68.
	2024-11-25	+0.99 %
Zoetis Inc. (NYSE:ZTS) saw a 0.99% increase in its stock price, supported by a strong consensus among analysts who give it an average "Buy" rating, positive recent earnings results, and upward revisions of price targets from several research firms. The stock's rise can be attributed to its solid quarterly earnings, which surpassed expectations, and positive analyst ratings, suggesting confidence in the company's financial performance and growth prospects.
	2024-11-21	+0.59 %
Zoetis Inc. (NYSE: ZTS) saw a 0.59% increase in its stock price, driven by strong quarterly earnings that exceeded analyst expectations, recent institutional investments, an upgraded consensus rating by analysts, and the declaration of a quarterly dividend.
	2024-11-19	-0.49 %
Zoetis (ZTS) stock decreased by 0.49% as institutional investors continue to adjust their holdings, though the company reported strong earnings and revenue in its latest quarterly results. The decline may reflect overall market trends or profit-taking despite positive financial performance, as the average rating for the stock remains "Buy."
	2024-11-13	+1.77 %
Zoetis Inc. (ZTS) stock rose 1.77% following a strong earnings report that exceeded analysts’ expectations and an increase in institutional investment, as multiple hedge funds expanded their holdings in the company.
	2024-11-11	-0.38 %
The article discusses Zoetis (ZTS), a leader in animal healthcare, which experienced a 0.38% decline in stock value due to unspecified market factors affecting investor sentiment or performance.
	2024-11-04	-3.72 %
Zoetis (ZTS) stock fell by 3.72% due to investor concerns related to broader market declines driven by global events and foreign fund outflows impacting investor sentiment. Zoetis (ZTS) stock declined by 3.72% due to broader market sell-offs driven by fears over global events, such as foreign fund outflows and geopolitical tensions, which negatively impacted investor sentiment across the pharmaceutical sector.
	2024-11-01	+1.77 %
Zoetis (ZTS) stock increased by 1.77% last night, likely due to a mix of positive quarterly earnings that surpassed expectations, strategic endorsements from analysts raising price targets, and increased institutional investment activity in the stock.
	2024-10-31	-2.17 %
The article discusses the recent challenges faced by genetic testing company 23andMe, including a significant board reshuffle and struggles with financial viability, while comparing it to the context of stock performance and market confidence. Zoetis (ZTS) stock was down due to broader market pressures likely influenced by the turmoil and financial challenges of companies like 23andMe, showcasing concerns over strategic management and profitability in similar sectors. Zoetis Inc. (ZTS) stock fell by 2.17% despite receiving an average "Buy" recommendation from analysts, as the recent slight downturn may be related to market reactions to broader economic conditions or profit-taking after a period of gains. Zoetis Inc. (ZTS) shares are down 2.17% despite receiving a consensus "Buy" rating from analysts, likely due to broader market trends or investor reactions unrelated to its strong analyst endorsements.
	2024-10-30	+0.81 %
The article reports that Zoetis Inc. (NYSE: ZTS) saw a 0.81% increase in its stock price, despite Adams Diversified Equity Fund Inc. reducing its position in the company by 33.3% in the third quarter. The stock's rise could be attributed to overall positive market sentiment or investor confidence in Zoetis, despite the fund's decision to decrease its holdings.
	2024-10-29	-0.82 %
Zoetis Inc. (ZTS) stock declined by 0.82% after Valley National Advisers Inc. reduced its holdings in the company by 18.8%, indicating potential negative sentiment among institutional investors. Zoetis Inc. (NYSE:ZTS) stock fell by 0.82% following abrdn plc's reduction of its stake in the company by 2.2%, which may reflect concerns about the company's future performance or investor sentiment.
	2024-10-28	+1.53 %
Zoetis Inc. (ZTS) stock rose 1.53% following reports that institutional investors, including Modera Wealth Management, significantly increased their stakes in the company, indicating strong investor confidence and interest in the stock. Zoetis (ZTS) stock increased by 1.53% following a report that Mirae Asset Global Investments expanded its holdings in the company by 28.6% during the 3rd quarter, indicating strong institutional confidence in the stock.
	2024-10-25	-0.82 %
Zoetis (ZTS) stock fell by 0.82% following a significant reduction in holdings by Assenagon Asset Management S.A., which cut its position in the company by 60.3% during the third quarter. Zoetis Inc. (ZTS) stock decreased by 0.82% following a report of various institutional investors adjusting their holdings, with CENTRAL TRUST Co reducing its stake by 1.8% in the third quarter and other funds increasing or establishing positions. Zoetis Inc. (NYSE: ZTS) saw a decline of 0.82% in its stock price, primarily influenced by market fluctuations and investor activity, despite receiving positive ratings and target price increases from several research analysts.